GRI Bio GRI
NASDAQ GRI
$1.96 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

GRI Bio (GRI) Other Accumulated Expenses (2020 - 2022)

Updated

GRI Bio's Other Accumulated Expenses came in at $104,000 for Q2 2022, up 14.3% from $91,000 a year earlier and up 4.0% from the prior quarter.

Analysis

GRI Bio (GRI) Other Accumulated Expenses (2020 - 2022) Analysis & Trends

At the end of FY2021, GRI Bio's Other Accumulated Expenses was $97,000, down 7.6% from FY2020.

  • Going back by year, Other Accumulated Expenses was $105,000 in FY2020.
  • The Q2 2022 figure represents the highest quarterly Other Accumulated Expenses since Q4 2020.
  • Business Quant data shows GRI's Other Accumulated Expenses at $100,000 (Q1 2022), $97,000 (Q4 2021) and $94,000 (Q3 2021) in the three quarters before Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 GRI Bio 3.54 Mn 3.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 104,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 97,000.00
Sep 30, 2021 94,000.00
Jun 30, 2021 91,000.00
Mar 31, 2021 89,000.00
Dec 31, 2020 105,000.00
API Access

GRI Bio Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=GRI&period=max&api_key=YOUR_API_KEY